Takeda Pharmaceuticals International Ag opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Takeda Pharmaceuticals International Ag

Patent Number:
Title:
Stable Liquid Fibrinogen
Opposition Date:
Jun 5, 2024
Patent Number:
Title:
Improved Process For The Preparation Of Immunoglobulin G (Igg)
Opposition Date:
May 29, 2019
Patent Number:
Title:
Immunoglobulin G (Igg) Concentrate Depleted Of Anti-A And Anti-B Antibodies And Of Polyreactive Iggs
Opposition Date:
Apr 11, 2019

Want to track Takeda Pharmaceuticals International Ag?

Feel free to send us a message here and we will get back to you